Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piers Blombery

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
British Journal of Haematology|October 24, 2022
A novel ATRX variant with splicing consequences in myelodysplastic syndrome with acquired alpha thalassaemiaPhillip C Nguyen, Ing Soo Tiong, David A Westerman, et al.
International Journal of Laboratory Hematology|March 6, 2020
Diagnostic evaluation and considerations in hypocellular bone marrow failure-A focus on genomicsLucy C Fox, Erica M Wood, David S Ritchie, et al.
Leukemia & Lymphoma|December 22, 2024
Genomic mechanisms associated with resistance to PDL1-blockade in a patient with mantle cell lymphomaSamuel Grigg, Stephen Lade, Georgina Ryland, et al.
British Journal of Haematology|April 8, 2026
HAT-PCR is non-inferior to NGS when quantifying measurable residual disease for myelomaElizabeth Hughes, Piers Blombery, Sushmitha Kannan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphomaPiers Blombery, H Miles Prince, Michele Levinson, et al.
Leukemia & Lymphoma|September 17, 2013
Plasma cell neoplasm associated chronic neutrophilic leukemia with membrane proximal and truncating CSF3R mutationsPiers Blombery, Jaimal Kothari, Kwee Yong, et al.
European Journal of Haematology|February 14, 2022
Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic reviewMartin Vu, Koen Degeling, Ella R Thompson, et al.
Leukemia & Lymphoma|June 21, 2021
Cryptic molecular lesion in acute promyelocytic leukemia with negative initial FISHJasmine Singh, Adam Facey, Fran O'Malley, et al.
Leukemia & Lymphoma|October 31, 2025
Donor-derived somatic genetic rescue with prolonged hematopoietic stability following sibling allogeneic stem cell transplant in <i>SAMD9</i> syndromeMichelle Tan, Nicole den Elzen, Erin Goode, et al.
Applied Health Economics and Health Policy|August 23, 2023
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in AustraliaMartin Vu, Koen Degeling, Ella R Thompson, et al.
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|October 24, 2022
A novel ATRX variant with splicing consequences in myelodysplastic syndrome with acquired alpha thalassaemiaPhillip C Nguyen, Ing Soo Tiong, David A Westerman, et al.
International Journal of Laboratory Hematology|March 6, 2020
Diagnostic evaluation and considerations in hypocellular bone marrow failure-A focus on genomicsLucy C Fox, Erica M Wood, David S Ritchie, et al.
Leukemia & Lymphoma|December 22, 2024
Genomic mechanisms associated with resistance to PDL1-blockade in a patient with mantle cell lymphomaSamuel Grigg, Stephen Lade, Georgina Ryland, et al.
British Journal of Haematology|April 8, 2026
HAT-PCR is non-inferior to NGS when quantifying measurable residual disease for myelomaElizabeth Hughes, Piers Blombery, Sushmitha Kannan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphomaPiers Blombery, H Miles Prince, Michele Levinson, et al.
Leukemia & Lymphoma|September 17, 2013
Plasma cell neoplasm associated chronic neutrophilic leukemia with membrane proximal and truncating CSF3R mutationsPiers Blombery, Jaimal Kothari, Kwee Yong, et al.
European Journal of Haematology|February 14, 2022
Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic reviewMartin Vu, Koen Degeling, Ella R Thompson, et al.
Leukemia & Lymphoma|June 21, 2021
Cryptic molecular lesion in acute promyelocytic leukemia with negative initial FISHJasmine Singh, Adam Facey, Fran O'Malley, et al.
Leukemia & Lymphoma|October 31, 2025
Donor-derived somatic genetic rescue with prolonged hematopoietic stability following sibling allogeneic stem cell transplant in <i>SAMD9</i> syndromeMichelle Tan, Nicole den Elzen, Erin Goode, et al.
Applied Health Economics and Health Policy|August 23, 2023
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in AustraliaMartin Vu, Koen Degeling, Ella R Thompson, et al.
Pageof 16